Effects of hypoxia on human cancer cell line chemosensitivity - PubMed (original) (raw)
Effects of hypoxia on human cancer cell line chemosensitivity
Sara Strese et al. BMC Cancer. 2013.
Abstract
Background: Environment inside even a small tumor is characterized by total (anoxia) or partial oxygen deprivation, (hypoxia). It has been shown that radiotherapy and some conventional chemotherapies may be less effective in hypoxia, and therefore it is important to investigate how different drugs act in different microenvironments. In this study we perform a large screening of the effects of 19 clinically used or experimental chemotherapeutic drugs on five different cell lines in conditions of normoxia, hypoxia and anoxia.
Methods: A panel of 19 commercially available drugs: 5-fluorouracil, acriflavine, bortezomib, cisplatin, digitoxin, digoxin, docetaxel, doxorubicin, etoposide, gemcitabine, irinotecan, melphalan, mitomycin c, rapamycin, sorafenib, thalidomide, tirapazamine, topotecan and vincristine were tested for cytotoxic activity on the cancer cell lines A2780 (ovarian), ACHN (renal), MCF-7 (breast), H69 (SCLC) and U-937 (lymphoma). Parallel aliquots of the cells were grown at different oxygen pressures and after 72 hours of drug exposure viability was measured with the fluorometric microculture cytotoxicity assay (FMCA).
Results: Sorafenib, irinotecan and docetaxel were in general more effective in an oxygenated environment, while cisplatin, mitomycin c and tirapazamine were more effective in a low oxygen environment. Surprisingly, hypoxia in H69 and MCF-7 cells mostly rendered higher drug sensitivity. In contrast ACHN appeared more sensitive to hypoxia, giving slower proliferating cells, and consequently, was more resistant to most drugs.
Conclusions: A panel of standard cytotoxic agents was tested against five different human cancer cell lines cultivated at normoxic, hypoxic and anoxic conditions. Results show that impaired chemosensitivity is not universal, in contrast different cell lines behave different and some drugs appear even less effective in normoxia than hypoxia.
Figures
Figure 1
The effect of drugs generally more effective in oxygen deprived environment. Cisplatin (A and B), mitomycin c (C and D) and tirapazamine (E and F) in ACHN (renal adenocarcinoma) and H69 (small lung cancer) cell lines in anoxic, hypoxic and normoxic surroundings. Error bars denote SEM.
Figure 2
The effect of drugs generally less effective in oxygen deprived environment. Docetaxel (A and B) and irinotecan (C and D) in ACHN (renal adenocarcinoma) and H69 (small lung cancer) cell lines in anoxic, hypoxic and normoxic surroundings. Error bars denote SEM.
Figure 3
Gene set enrichment analysis. Results based on gene expression data from breast cancer cells (MCF-7 cell line) incubated in hypoxia (1.0% O2) compared to normoxia (20% O2) for 90 hrs. Enrichment profile shows an association of hypoxia-associated genes among the genes up-regulated when incubated in hypoxia.
Similar articles
- Hypoxia modulates the activity of a series of clinically approved tyrosine kinase inhibitors.
Ahmadi M, Ahmadihosseini Z, Allison SJ, Begum S, Rockley K, Sadiq M, Chintamaneni S, Lokwani R, Hughes N, Phillips RM. Ahmadi M, et al. Br J Pharmacol. 2014 Jan;171(1):224-36. doi: 10.1111/bph.12438. Br J Pharmacol. 2014. PMID: 24117380 Free PMC article. - Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X, Liu X, Chi W, Liu Y, Wei L, Wang X, Yu J. Song X, et al. Cancer Chemother Pharmacol. 2006 Dec;58(6):776-84. doi: 10.1007/s00280-006-0224-7. Epub 2006 Mar 11. Cancer Chemother Pharmacol. 2006. PMID: 16532342 - Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro.
Koch S, Mayer F, Honecker F, Schittenhelm M, Bokemeyer C. Koch S, et al. Br J Cancer. 2003 Dec 1;89(11):2133-9. doi: 10.1038/sj.bjc.6601375. Br J Cancer. 2003. PMID: 14647149 Free PMC article. - Genetically defined subsets of human pancreatic cancer show unique in vitro chemosensitivity.
Cui Y, Brosnan JA, Blackford AL, Sur S, Hruban RH, Kinzler KW, Vogelstein B, Maitra A, Diaz LA Jr, Iacobuzio-Donahue CA, Eshleman JR. Cui Y, et al. Clin Cancer Res. 2012 Dec 1;18(23):6519-30. doi: 10.1158/1078-0432.CCR-12-0827. Epub 2012 Jul 2. Clin Cancer Res. 2012. PMID: 22753594 Free PMC article. - Allicin Overcomes Hypoxia Mediated Cisplatin Resistance in Lung Cancer Cells through ROS Mediated Cell Death Pathway and by Suppressing Hypoxia Inducible Factors.
Pandey N, Tyagi G, Kaur P, Pradhan S, Rajam MV, Srivastava T. Pandey N, et al. Cell Physiol Biochem. 2020 Aug 19;54(4):748-766. doi: 10.33594/000000253. Cell Physiol Biochem. 2020. PMID: 32809300
Cited by
- A Spatially Resolved Mechanistic Growth Law for Cancer Drug Development Predicting Tumor Growing Fractions.
Nasim A, Yates J, Derks G, Dunlop C. Nasim A, et al. Cancer Res Commun. 2022 Aug 2;2(8):754-761. doi: 10.1158/2767-9764.CRC-22-0032. eCollection 2022 Aug. Cancer Res Commun. 2022. PMID: 36923310 Free PMC article. - Hypoxia-targeted drug delivery.
Sharma A , Arambula JF , Koo S , Kumar R , Singh H , Sessler JL , Kim JS . Sharma A , et al. Chem Soc Rev. 2019 Feb 4;48(3):771-813. doi: 10.1039/c8cs00304a. Chem Soc Rev. 2019. PMID: 30575832 Free PMC article. Review. - Efficacy of atovaquone on EpCAM+CD44+ HCT-116 human colon cancer stem cells under hypoxia.
Fu C, Xiao X, Xu H, Lu W, Wang Y. Fu C, et al. Exp Ther Med. 2020 Dec;20(6):286. doi: 10.3892/etm.2020.9416. Epub 2020 Oct 29. Exp Ther Med. 2020. PMID: 33209130 Free PMC article. - Preclinical activity of melflufen (J1) in ovarian cancer.
Carlier C, Strese S, Viktorsson K, Velander E, Nygren P, Uustalu M, Juntti T, Lewensohn R, Larsson R, Spira J, De Vlieghere E, Ceelen WP, Gullbo J. Carlier C, et al. Oncotarget. 2016 Sep 13;7(37):59322-59335. doi: 10.18632/oncotarget.11163. Oncotarget. 2016. PMID: 27528037 Free PMC article. - Liver Cancer Cell Lines Treated with Doxorubicin under Normoxia and Hypoxia: Cell Viability and Oncologic Protein Profile.
Dubbelboer IR, Pavlovic N, Heindryckx F, Sjögren E, Lennernäs H. Dubbelboer IR, et al. Cancers (Basel). 2019 Jul 20;11(7):1024. doi: 10.3390/cancers11071024. Cancers (Basel). 2019. PMID: 31330834 Free PMC article.
References
- Durand RE, Raleigh JA. Identification of nonproliferating but viable hypoxic tumor cells in vivo. Cancer Res. 1998;58(16):3547–3550. - PubMed
- Evans SM, Joiner B, Jenkins WT, Laughlin KM, Lord EM, Koch CJ. Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] Br J Cancer. 1995;72(4):875–882. doi: 10.1038/bjc.1995.427. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources